Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib plus Chemotherapy in Advanced Non-Squamous NSCLC
NCT02264990Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2014
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of veliparib in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by AbbVie Inc.. Started Sep 2014; status: completed.
02
Drugs
veliparib
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT02264990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02264990.